* Clover Health Investments Corp CLOV.OQ CLOV.O is
expected
to show a fall in quarterly revenue when it reports results
* The Franklin Tennessee-based company is expected to
report a
42.3% decrease in revenue to $494.6 million from $856.82 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
* Refinitiv's mean analyst estimate for Clover Health
Investments
Corp is for a loss of 11 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clover
Health
Investments Corp is $1.63, above its last closing price
of $1.09.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.15 -0.15 -0.06 Beat 60.1
Mar. 31 2023 -0.17 -0.18 -0.15 Beat 14.7
Dec. 31 2022 -0.23 -0.26 -0.17 Beat 31.4
Sep. 30 2022 -0.25 -0.24 -0.16 Beat 33.1
Jun. -0.21 -0.21 -0.22 Missed -6.7
30 2022
Mar. 31 2022 -0.28 -0.27 -0.19 Beat 30.5
Dec. 31 2021 -0.27 -0.26 -0.28 Missed -7.9
Sep. 30 2021 -0.24 -0.23 -0.08 Beat 65
This summary was machine generated November 4 at 00:51 GMT. All
figures in US dollars unless otherwise stated